Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Influenza and Other Respiratory Viruses|July 23, 2021
Distinguishing repeated polymerase chain reaction positivity from re-infections in COVID-19Sara Sadr, Melika Arab Bafrani, Alireza Abdollahi, et al.
Daru : Journal of Faculty of Pharmacy, Tehran University of Medical Sciences|August 29, 2020
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavirHamid Rahmani, Effat Davoudi-Monfared, Anahid Nourian, et al.
European Journal of Medical Research|February 4, 2022
The outcome of using intravenous immunoglobulin (IVIG) in critically ill COVID-19 patients': a retrospective, multi-centric cohort studyMohammadreza Salehi, Mahdi Barkhori Mehni, Mohammadmehdi Akbarian, et al.
Mycoses|July 2, 2020
Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: Species identification and antifungal susceptibility patternMohammadreza Salehi, Kazem Ahmadikia, Shahram Mahmoudi, et al.
Archives of Iranian Medicine|April 17, 2022
Rapid Detection Test for COVID-19 among Healthcare Workers and the Role of Personal Protective EquipmentMahboubeh Hajiabdolbaghi, Armin Aryannejad, Mohammadreza Tabary, et al.
European Journal of Medical Research|February 12, 2021
Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trialSaeidreza JamaliMoghadamSiahkali, Besharat Zarezade, Sogol Koolaji, et al.
European Journal of Medical Research|May 7, 2021
Predictors of the prolonged recovery period in COVID-19 patients: a cross-sectional studySeyedAhmad SeyedAlinaghi, Ladan Abbasian, Mohammad Solduzian, et al.
International Journal of Antimicrobial Agents|August 28, 2020
Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trialEhsan Sekhavati, Fatemeh Jafari, SeyedAhmad SeyedAlinaghi, et al.
Inflammopharmacology|February 24, 2022
Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trialSepideh Barzin Tond, Laurent Balenci, Nasim Khajavirad, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 11, 2022
Efficacy of a multiple-indication antiviral herbal drug (Saliravira®) for COVID-19 outpatients: A pre-clinical and randomized clinical trial studyReza Ramazani Khorshiddoust, Saleh Ramazani Khorshiddoust, Tahereh Hosseinabadi, et al.
Pageof 4